About Baird
Families & Individuals
Corporations & Institutions
Baird Research & Insights
Contact Us
Client Login
Individuals - Baird OnLine
Institutions
Corporations & Institutions
Investment Banking
M&A Recent Transactions
Deal Card
Investment Banking
Conferences
Asset Management
Private Equity
Fixed Income Sales and Trading
Equity Sales and Trading
Executive Services
Public Finance
Corporate Services
Institutional Consulting
Contact Us
Mergers and Acquisitions
Equity Financing
Corporate Restructuring
Industries of Focus
Financial Sponsors
Team Bios
News
Investment Banking Accolades
M&A Expertise
M&A Services
M&A Recent Transactions
Equity Financing Expertise
Equity Financing Services
Recent Financing Transactions
Corporate Restructuring Expertise
Corporate Restructuring Services
Business Services
Clean Technology
Consumer
Distribution
Energy
Financial Services
Healthcare
Industrial
Real Estate
Technology
Utilities
Financial Sponsors Recent Transactions
Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
October 2009
Primaeva Medical, Inc.
Sale to Syneron Medical Ltd.
Baird served as the exclusive financial advisor to Primaeva Medical, Inc.
Primaeva Medical, Inc. (“Primaeva”) recently completed its sale to Syneron Medical Ltd. ("Syneron") (NASDAQ: ELOS). Under the terms of the agreement, Syneron acquired Primaeva for $7 million in cash and an additional consideration of $23 million in cash based on achieving certain post-closing commercial milestones.
Based in Pleasanton, CA, Primaeva was founded in 2005. The company has developed a patented, minimally invasive technology for aesthetic application. Development of Primaeva’s first product is complete and is intended to improve aesthetic results by increasing the efficiency and control of sub-dermal RF energy. Previous investors include Frazier Healthcare Ventures, Delphi Ventures and Affinity Capital Management.
Syneron Medical Ltd. manufactures and distributes medical aesthetic devices based on its proprietary elos combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction and skin rejuvenation. Founded in 2000, Syneron’s corporate, R&D, and manufacturing headquarters are located in Israel and maintains its North American headquarters in Irvine, CA.
For additional information about this transaction, please contact:
Managing Director
(650) 858-3813
Careers
|
Help
|
Site Map
|
Important Disclosures
|
Privacy Policy
|
Financial Information
|
Business Continuity
©2013 Robert W. Baird & Co. Incorporated.
Global Websites:
Europe
|
Asia
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see
Important Disclosures
. Robert W. Baird & Co. Incorporated. Member
SIPC
.